You have 9 free searches left this month | for more free features.

anti asthmatic agents

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Respiratory System Agents, Anti-Asthmatic Agents, Hematologic Diseases Trial run by the NIAID (benralizumab, Placebo)

Active, not recruiting
  • Respiratory System Agents
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 20, 2022

Agents, Anti Asthmatic, Asthma in Children Trial in Nijmegen ("100 mcg Salbutamol Sandoz" and "300 mcg Salbutamol Sandoz", "100

Recruiting
  • Agents, Anti Asthmatic
  • Asthma in Children
  • "100 mcg Salbutamol Sandoz" and "300 mcg Salbutamol Sandoz"
  • +3 more
  • Nijmegen, Gelderland, Netherlands
    Canisius Wilhelmina Hospital
May 22, 2023

Advanced Solid Tumor Trial (SHR-A1921;)

Not yet recruiting
  • Advanced Solid Tumor
  • (no location specified)
Feb 28, 2023

Stroke, Medication Adherence Trial in Kumasi (Polycap)

Not yet recruiting
  • Stroke
  • Medication Adherence
  • Kumasi, Ghana
    Kwame Nkrumah Institute of Science & Technology
Jul 19, 2023

Uncomplicated Plasmodium Falciparum Malaria Trial (INE963, KAE609, SoC (Coartem))

Not yet recruiting
  • Uncomplicated Plasmodium Falciparum Malaria
  • (no location specified)
Feb 17, 2023

Osteomyelitis-associated Pressure Ulcers by Surgical Flaps and

Not yet recruiting
  • Disability or Chronic Disease Leading to Disablement
  • +2 more
  • Surgical flap and anti-bacterial agents
  • Garches, France
    Department of Physical Medicine and Rehabilitation, Raymond Poin
Feb 1, 2023

Relapsed/Refractory Non-Hodgkin Lymphoma Trial in Duarte, Amsterdam (BMS-986458, Rituximab)

Not yet recruiting
  • Relapsed/Refractory Non-Hodgkin Lymphoma
  • Duarte, California
  • +1 more
Oct 13, 2023

Solid Tumor Trial in Chuo-ku (ROSE12, Atezolizumab)

Recruiting
  • Solid Tumor
  • Chuo-ku, Tokyo, Japan
    National Cancer Center Hospital
Jun 14, 2023

NSCLC Trial (BGB-A445, Docetaxel, Tislelizumab)

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • (no location specified)
Sep 6, 2023

Cancer, Tumor, Solid, Malignant Tumor Trial (OR502, Cemiplimab)

Not yet recruiting
  • Cancer
  • +6 more
  • (no location specified)
Oct 16, 2023

Atherosclerosis, Adherence, Medication, Tolerance Trial in Kumasi (Polycap)

Completed
  • Atherosclerosis
  • +2 more
  • Kumasi, Ghana
    Kwame Nkrumah University of Science & Technology
Sep 29, 2022

Crohn's Disease, Ulcerative Colitis Trial in Montpellier (Immuno monitoring)

Completed
  • Crohn's Disease
  • Ulcerative Colitis
  • Immuno monitoring
  • Montpellier, France
    University hospital
Dec 13, 2022

Ovarian Cancer, Lung Adenocarcinoma Trial in United States (AZD5335, AZD5305)

Not yet recruiting
  • Ovarian Cancer
  • Lung Adenocarcinoma
  • Duarte, California
  • +6 more
Mar 21, 2023

IBD, Biological Substance; Adverse Effect Trial in Haifa (Azithromycin Pill, Placebo)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • Biological Substance; Adverse Effect
  • Azithromycin Pill
  • Placebo
  • Haifa, Israel
    Rambam Health Care Campus
Oct 25, 2022

Mild Cognitive Impairment, Alzheimer Trial in Worldwide (Canakinumab, Placebo)

Recruiting
  • Mild Cognitive Impairment
  • Alzheimer Disease
  • Canakinumab
  • Placebo
  • Charlestown, Massachusetts
  • +11 more
Nov 11, 2022

Tumors Trial run by the NCI (Nilotinib and Paclitaxel)

Recruiting
  • Neoplasms
  • Nilotinib and Paclitaxel
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Sports Drug Abuse Trial (Inhaled salbutamol)

Withdrawn
  • Sports Drug Abuse
  • Inhaled salbutamol
  • (no location specified)
Mar 9, 2022

Risk of NSAIDs on Anastomotic Leak for Rectal Surgery

Recruiting
  • Anastomotic Leak
  • Anti-Inflammatory Agents, Non-Steroidal
    • Chongqing, None Selected, China
      Army Medical Center
    Nov 24, 2023

    Osteoarthritis, Knee Trial in Vail (Fisetin, Losartan, Placebo - Losartan)

    Recruiting
    • Osteoarthritis, Knee
    • Vail, Colorado
      The Steadman Clinic
    Oct 6, 2022

    Treatment Resistant Depression, MDD, Analgesia Trial in Brooklyn (VTS-K)

    Recruiting
    • Treatment Resistant Depression
    • +12 more
    • Brooklyn, New York
      Maimonides Medical Center
    Dec 12, 2022

    PTSD, Alcohol Use Disorder Trial in Baltimore (Pregabalin plus BBCET, Placebo plus BBCET)

    Active, not recruiting
    • PTSD
    • Alcohol Use Disorder
    • Pregabalin plus BBCET
    • Placebo plus BBCET
    • Baltimore, Maryland
      University of Maryland School of Medicine
    Mar 25, 2022

    Collateral Damage From COVID-19 Pandemic Observed in Patients

    Completed
    • Age Related Macular Degeneration
    • +2 more
    • Questionnaire
    • Data collection up to 1 year
    • Ecully, France
    • +3 more
    Mar 2, 2022

    Clinical Trials of Investigational or Licensed Vaccines or

    Recruiting
    • Vaccines
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      Anti-HLA Immunization And Immunosuppressive Therapy Management

      Active, not recruiting
      • Kidney Transplantation
      • +3 more
      • management of immunosuppressive therapy
      • Nancy, Lorraine, France
        Central HNF
      Mar 24, 2022

      Anti-angiogenic Agents Plus Anti-PD-1 Antibodies for uHCC

      Recruiting
      • Hepatocellular Carcinoma
      • Anti-angiogenic agents plus anti-PD-1/PD-L1 antibodies
      • Shanghai, Shanghai, China
        Zhongshan Hospital, Fudan University
      Jul 23, 2021